Missense mutations in codon 132 of IDH1 or codon 172 of IDH2 are the defining molecular feature of IDH-mutant astrocytomas and are associated with the glioma CpG island methylator phenotype (G-CIMP). The gene discussed is IDH1; the disease is astrocytoma (excluding glioblastoma).